Advertisement
UK markets open in 6 hours 9 minutes

  • NIKKEI 225

    37,781.12
    -180.68 (-0.48%)
     

  • HANG SENG

    16,251.84
    +2.87 (+0.02%)
     

  • CRUDE OIL

    82.70
    +0.01 (+0.01%)
     

  • GOLD FUTURES

    2,384.30
    -4.10 (-0.17%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • Bitcoin GBP

    49,260.52
    -2,271.66 (-4.41%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,683.37
    -181.88 (-1.15%)
     

  • UK FTSE All Share

    4,273.02
    +12.61 (+0.30%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

Oxford BioMedica inks deal to make AstraZeneca's potential COVID-19 vaccine

Reuters
Updated
FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield

(Reuters) - Britain's Oxford BioMedica <OXB.L> has agreed with AstraZeneca to manufacture the drugmaker's experimental COVID-19 vaccine, the cell therapy company said on Thursday.

Oxford BioMedica will provide the drugmaker withmultiple batches of the vaccine, called AZD1222, under a one-year clinical and commercial supply agreement, the company said, adding that the majority of it is expected be produced throughout 2020.

Oxford BioMedica shares were up 7.3% at 769 pence after the announcement.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)